Summit Therapeutics Inc.SMMTNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+175.2%
5Y CAGR+96.0%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+175.2%/yr
vs +11.9%/yr prior
5Y CAGR
+96.0%/yr
Recent acceleration
Acceleration
+163.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
28.9x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $556.75M | +819.8% |
| 2024 | $60.53M | +100.0% |
| 2023 | $30.27M | +13.4% |
| 2022 | $26.70M | +13.1% |
| 2021 | $23.61M | +22.8% |
| 2020 | $19.23M | +106.8% |
| 2019 | $9.30M | -45.3% |
| 2018 | $17.01M | +24.1% |
| 2017 | $13.71M | +42.6% |
| 2016 | $9.62M | - |